---
figid: PMC6923788__mdz281f1
figlink: /pmc/articles/PMC6923788/figure/mdz281-F1/
number: F1
caption: Signaling by the phosphatidylinositol-3-kinase (PI3K)-AKT- mammalian target
  of rapamycin (mTOR) pathway. The PI3K-AKT-mTOR pathway is activated by various growth
  factor receptors such as HER2, fibroblast growth factor receptor 1 (FGFR1), insulin-like
  growth factor 1 R (IGF1R) among others. PI3K proteins are recruited to the plasma
  membrane, leading to phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2)
  to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 recruits to the
  membrane the AKT kinases that, once activated by PDK1 and mTORC2 phosphorylation,
  are able to phosphorylate TSC2 and negatively regulate the activity of the kinase
  mTOR. mTORC1 also phosphorylates and activates S6K. Also shown are few examples
  of PI3K-AKT-mTOR inhibitors in clinical trials.
pmcid: PMC6923788
papertitle: Overview of the relevance of PI3K pathway in HR-positive breast cancer.
reftext: N Vasan, et al. Ann Oncol. 2019 Dec;30(Suppl 10):x3-x11.
pmc_ranked_result_index: '23608'
pathway_score: 0.963081
filename: mdz281f1.jpg
figtitle: Signaling by the phosphatidylinositol-3-kinase (PI3K)-AKT- mammalian target
  of rapamycin (mTOR) pathway
year: '2019'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6923788__mdz281f1.html
  '@type': Dataset
  description: Signaling by the phosphatidylinositol-3-kinase (PI3K)-AKT- mammalian
    target of rapamycin (mTOR) pathway. The PI3K-AKT-mTOR pathway is activated by
    various growth factor receptors such as HER2, fibroblast growth factor receptor
    1 (FGFR1), insulin-like growth factor 1 R (IGF1R) among others. PI3K proteins
    are recruited to the plasma membrane, leading to phosphorylation of phosphatidylinositol
    4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3).
    PIP3 recruits to the membrane the AKT kinases that, once activated by PDK1 and
    mTORC2 phosphorylation, are able to phosphorylate TSC2 and negatively regulate
    the activity of the kinase mTOR. mTORC1 also phosphorylates and activates S6K.
    Also shown are few examples of PI3K-AKT-mTOR inhibitors in clinical trials.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB2
  - FGFR1
  - IGF1R
  - AKT2
  - AKT3
  - AKT1
  - PDK1
  - SART3
  - TSC2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - Everolimus
  - Temsirolimus
  - AZD8055
  - GDC-0077
  - AZD6363
  - SF1126
  - LY3023414
genes:
- word: HER2,
  symbol: HER2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: FGFR1,
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: IGFIR)
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: (e.g.HER2,FGFR1,IGFIR)
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: Everolimus
  source: MESH
  identifier: C107135
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: AZD8055
  source: MESH
  identifier: C546624
- word: GDC-0077
  source: MESH
  identifier: C078631
- word: AZD6363
  source: MESH
  identifier: C049284
- word: SF1126
  source: MESH
  identifier: C526549
- word: LY3023414
  source: MESH
  identifier: C430423
diseases: []
figid_alias: PMC6923788__F1
redirect_from: /figures/PMC6923788__F1
figtype: Figure
---
